OncoDaily Medical Journal Bolsters Editorial Team with Ten Leading oncology Experts
NEW YORK – November 22, 2025 – OncoDaily Medical Journal has considerably expanded it’s editorial capabilities with the addition of ten internationally recognized oncology experts. The new team members, hailing from institutions across Europe and turkey, bring a wealth of clinical, research, and academic experience to the rapidly growing medical publication. This expansion underscores OncoDaily’s commitment to delivering cutting-edge,peer-reviewed oncology content to healthcare professionals worldwide.
The influx of expertise arrives at a critical juncture in cancer care, marked by accelerating advancements in immunotherapy, targeted therapies, and precision medicine. By strengthening its editorial board, OncoDaily aims to provide clinicians and researchers with the most current, insightful analysis of these developments, ultimately improving patient outcomes. The new additions will contribute to the journal’s rigorous review process, ensuring the highest standards of scientific accuracy and clinical relevance.
The ten newly appointed experts are:
- Daniela Filomena, MD, PhD (Italy): Attending physician, Department of Oncology, IRCCS AOU San Raffaele, Milan, Italy.
- Nikhil Joshi, MD (United Kingdom): Consultant Medical oncologist, The Christie NHS Foundation Trust, Manchester, United Kingdom.
- Spyridon Vlachakis, MD, PhD (greece): Attending Physician, Oncology Unit, University Hospital of Heraklion, Crete, Greece.
- Ioannis Ntanasis-Stathopoulos, MD, PhD (Greece): associate Professor of Oncology, Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Enes Yeşilbaş, MD (Turkey): Medical Oncology Fellow & Researcher at Department of Medical Oncology, Ankara Etlik City Hospital, Türkiye.
- Livia Onofrio, MD, PhD (Italy): [Further details not provided in source text].
- [Names and affiliations for experts 7-10 were not provided in the source text.]
- [Names and affiliations for experts 7-10 were not provided in the source text.]
- [Names and affiliations for experts 7-10 were not provided in the source text.]
- [Names and affiliations for experts 7-10 were not provided in the source text.]
OncoDaily Medical journal anticipates that the expanded editorial team will facilitate a broader scope of coverage, including emerging treatment modalities, novel biomarkers, and innovative clinical trial designs. Further details regarding the contributions of the full team will be announced in the coming weeks.
